首页> 外文期刊>Radiation Research: Official Organ of the Radiation Research Society >Modifying Normal Tissue Damage Postirradiation report of a workshop sponsored by the Radiation Research Program, National Cancer Institute, Bethesda, Maryland - September 6-8, 2000 - Meeting report [Review]
【24h】

Modifying Normal Tissue Damage Postirradiation report of a workshop sponsored by the Radiation Research Program, National Cancer Institute, Bethesda, Maryland - September 6-8, 2000 - Meeting report [Review]

机译:马里兰州贝塞斯达国家癌症研究所放射研究计划赞助的研讨会的“正常组织损伤后照射后修改”报告-2000年9月6日至8日-会议报告[审查]

获取原文
获取原文并翻译 | 示例
           

摘要

Late effects that develop in normal tissues adjacent to the tumor site in the months to years after radiotherapy can reduce the quality of life of cancer survivors. They can be dose-limiting and debilitating or life-threatening. There is now evidence that some late effects may be preventable or partially reversible. A workshop, "Modifying Normal Tissue Damage Postirradiation", was sponsored by the Radiation Research Program of the National Cancer Institute to identify the current status of and research needs and opportunities in this area. Mechanistic, genetic and physiological studies of the development of late effects are needed and will provide a rational basis for development of treatments. Interdisciplinary teams will be needed to carry out this research, including pathologists, physiologists, geneticists, molecular biologists, experts in functional imaging, wound healing, burn injury, molecular biology, and medical oncology, in addition to radiation biologists, physicists and oncologists. The participants emphasized the need for developing and choosing appropriate models, and for radiation dose-response studies to determine whether interventions remain effective at the radiation doses used clinically. Both preclinical and clinical studies require long-term follow-up, and easier-to-use, more objective clinical scoring systems must be developed and standardized. New developments in biomedical imaging should provide useful tools in all these endeavors. The ultimate goals are to improve the quality of life and efficacy of treatment for cancer patients treated with radiotherapy. (C) 2002 by Radiation Research Society. [References: 159]
机译:放疗后数月至数年,邻近肿瘤部位的正常组织中出现的晚期效应会降低癌症幸存者的生活质量。它们可能会限制剂量,使人衰弱或威胁生命。现在有证据表明某些后期影响可能是可预防的或部分可逆的。由美国国家癌症研究所的放射研究计划赞助的研讨会“改变正常的组织损伤后照射”,旨在确定该领域的现状和研究需求与机遇。需要对后期效应的发展进行机械,遗传和生理学研究,这些研究将为开发治疗方法提供合理的基础。除了放射生物学家,物理学家和肿瘤学家之外,还需要跨学科的团队来进行这项研究,包括病理学家,生理学家,遗传学家,分子生物学家,功能成像,伤口愈合,烧伤,分子生物学和医学肿瘤学方面的专家。参与者强调需要开发和选择合适的模型,以及进行辐射剂量反应研究以确定干预措施是否在临床使用的辐射剂量下仍然有效。临床前和临床研究都需要长期随访,必须开发和标准化易于使用,更客观的临床评分系统。生物医学成像的新发展应为所有这些努力提供有用的工具。最终目标是改善接受放射治疗的癌症患者的生活质量和治疗效果。 (C)2002年,辐射研究学会。 [参考:159]

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号